Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/24103
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBRUYNDONCKX, Robin-
dc.contributor.authorHENS, Niel-
dc.contributor.authorAERTS, Marc-
dc.contributor.authorGoossens, Herman-
dc.contributor.authorLatour, Katrien-
dc.contributor.authorCatry, Boudewijn-
dc.contributor.authorCoenen, Samuel-
dc.date.accessioned2017-08-07T09:26:02Z-
dc.date.available2017-08-07T09:26:02Z-
dc.date.issued2017-
dc.identifier.citationJOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 8, p. 6-12-
dc.identifier.issn2213-7165-
dc.identifier.urihttp://hdl.handle.net/1942/24103-
dc.description.abstractObjectives: To assess whether persistence of antimicrobial resistance (i.e. non-susceptible resistance status) after treatment with penicillins or cephalosporins versus macrolides or tetracyclines differs and to compare the results obtained using routinely collected data with findings reported in prospective studies. Methods: Routinely collected microbiological data from 14 voluntary participating laboratories (2005) containing information on resistance status and individual antimicrobial consumption patterns (mid 2004-2005) were analysed using a generalised estimating equation (GEE) approach. The link function was adjusted to acknowledge that the proportion of resistant isolates in the population not treated with antibiotics [baseline resistance (BR)] is not necessarily zero. To optimise the comparability of this study with prospective studies, the analysis was repeated after removal of 14 isolates from patients who did not survive 2005. Results: BR estimates were unstable and their confidence intervals were wide, which called for a sensitivity analysis using an adjusted GEE model with three different BR estimates. All models indicated that the proportion of susceptible isolates differed by treatment group and increased significantly over time, with this increase being independent of treatment group. Persistence of resistance after exposure to macrolides or tetracyclines was approximately three times as long as after exposure to penicillins or cephalosporins. Conclusions: Resistance following treatment with macrolides or tetracyclines persists longer than following treatment with penicillins or cephalosporins, which confirms the findings from prospective studies and suggests the use of routinely collected data as a valuable alternative to determine such differences in persistence of resistance. a 2016 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.-
dc.description.sponsorshipThe work was supported by the Methusalem Financing Programme of the Flemish government and the IAP Research Network P7/06 of the Belgian State (Belgian Science Policy). NH is supported by the University of Antwerp scientific chair in Evidence-Based Vaccinology, financed in 2009-16 by a gift from Pfizer. This study (IARG) was also supported by the Belgian National Council for the Promotion of Quality (Nationale Raad voor KwaliteitsPromotie; http://www.riziv.fgov.be/fr/inami/organes/Pages/cnpq.aspx).-
dc.language.isoen-
dc.publisherELSEVIER SCI LTD-
dc.rights(c) 2016 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.-
dc.subject.otherantimicrobial resistance; baseline resistance; generalised estimating equation; streptococcus pneumoniae; streptococcus pyogenes-
dc.subject.otherAntimicrobial resistance; Baseline resistance; Generalised estimating equation; Streptococcus pneumoniae; Streptococcus pyogenes-
dc.titlePersistence of antimicrobial resistance in respiratory streptococci-
dc.typeJournal Contribution-
dc.identifier.epage12-
dc.identifier.spage6-
dc.identifier.volume8-
local.format.pages7-
local.bibliographicCitation.jcatA1-
dc.description.notes[Bruyndonckx, Robin; Hens, Niel; Aerts, Marc] Univ Hasselt, Interuniv Inst Biostat & Stat Bioinformat I BIOST, Agoralaan 1, Hasselt, Belgium. [Bruyndonckx, Robin; Goossens, Herman; Coenen, Samuel] Univ Antwerp, Lab Med Microbiol, Vaccine & Infect Dis Inst VAXINFECTIO, Univ Pl 1, Antwerp, Belgium. [Hens, Niel] Univ Antwerp, Ctr Hlth Econ Res & Modelling Infect Dis, Vaccine & Infect Dis Inst VAXINFECTIO, Univ Pl 1, Antwerp, Belgium. [Latour, Katrien; Catry, Boudewijn] Sci Inst Publ Hlth WIV ISP, Juliette Wytsmanstr 14, Brussels, Belgium. [Coenen, Samuel] Univ Antwerp, Vaccine & Infect Dis Inst VAXINFECTIO, Ctr Gen Practice, Univ Pl 1, Antwerp, Belgium.-
local.publisher.placeOXFORD-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1016/j.jgar.2016.09.009-
dc.identifier.isi000398570500003-
dc.identifier.urlhttp://www.jgaronline.com/article/S2213-7165(16)30118-7/fulltext-
item.validationecoom 2018-
item.fullcitationBRUYNDONCKX, Robin; HENS, Niel; AERTS, Marc; Goossens, Herman; Latour, Katrien; Catry, Boudewijn & Coenen, Samuel (2017) Persistence of antimicrobial resistance in respiratory streptococci. In: JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 8, p. 6-12.-
item.contributorBRUYNDONCKX, Robin-
item.contributorHENS, Niel-
item.contributorAERTS, Marc-
item.contributorGoossens, Herman-
item.contributorLatour, Katrien-
item.contributorCatry, Boudewijn-
item.contributorCoenen, Samuel-
item.accessRightsOpen Access-
item.fulltextWith Fulltext-
crisitem.journal.issn2213-7165-
crisitem.journal.eissn2213-7173-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
bruyndonckx 1.pdfPublished version475.69 kBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

2
checked on Sep 2, 2020

WEB OF SCIENCETM
Citations

3
checked on May 8, 2024

Page view(s)

70
checked on Sep 7, 2022

Download(s)

250
checked on Sep 7, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.